ArticleAnnals of the rheumatic diseases2021
Response to: 'Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort' by Costa
Article in Annals of the rheumatic diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Real-world evidence for subcutaneous infliximab (CT-P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID-19) pandemic: A case series.Clinical case reports · 2022Article
- Assessment of a novel ophthalmology tele-triage system during the COVID-19 pandemic.BMC ophthalmology · 2021Article
- Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions.Rheumatology international · 2021Review
- Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands.Rheumatology international · 2021Observational
- Social Media for Scholarly Communication in Central Asia and Its Neighbouring Countries.Journal of Korean medical science · 2021Article
- Informed Consent for Scholarly Articles during the COVID-19 Pandemic.Journal of Korean medical science · 2021Article
- COVID-19: What Do Rheumatologists Need to Know?Current rheumatology reports · 2021Review
- Clinical and psychosocioeconomic impact of COVID-19 pandemic on patients of the Indian Progressive Systemic Sclerosis Registry (IPSSR).Rheumatology advances in practice · 2021Article
- Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic.Rheumatology international · 2021Observational
- Private Health Sector in India-Ready and Willing, Yet Underutilized in the Covid-19 Pandemic: A Cross-Sectional Study.Frontiers in public health · 2020Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32527864What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.